Alerts will be sent to your verified email
Verify Email
SARTHAKGL
|
Sarthak Global
|
Malabar Trading
|
Brawn Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-50.66 % | n/a | -11.92 % |
|
5yr Avg Net Profit Margin
|
-16.63 % | n/a | -6.0 % |
|
Price to Book
|
4.14 | n/a | 2.08 |
|
P/E
|
17.38 | n/a | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
29.16 Days | n/a | 67.06 Days |
|
5yr Average Interest Coverage Ratio
|
-0.35 | n/a | -18.52 |
|
5yr Avg ROCE
|
-1.54 % | n/a | -10.05 % |
|
5yr Avg Operating Profit Margin
|
-20.82 % | n/a | -6.76 % |
|
5 yr average Debt to Equity
|
6.84 | n/a | 0.0 |
|
5yr CAGR Net Profit
|
-25.98 % | n/a | n/a |
|
5yr Average Return on Assets
|
-2.88 % | n/a | -5.5 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.72 % | n/a | 53.66 % |
|
Share Pledged by Promoters
|
0.0 | n/a | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | n/a | -0.07 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | n/a | -0.24 % |
|
Sarthak Global
|
Malabar Trading
|
Brawn Biotech
|
|---|